| Literature DB >> 35197345 |
Javiera Leniz1, Lesley A Henson2, Jean Potter3, Wei Gao2, Tom Newsom-Davis4, Zia Ul-Haq5, Amanda Lucas5, Irene J Higginson2, Katherine E Sleeman2.
Abstract
OBJECTIVE: To examine the association between primary and community care use and measures of acute hospital use in people with cancer at the end of life.Entities:
Keywords: epidemiology; palliative care; primary care; quality in health care
Mesh:
Year: 2022 PMID: 35197345 PMCID: PMC8867349 DOI: 10.1136/bmjopen-2021-054281
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Sample characteristics by outcome measure
| All sample | 3 or more EHA last 3 months | 1 or more EHA last month | 1 or more ED visit in the last 2 weeks of life | |||||||||||||||
| No | Yes | No | Yes | No | Yes | |||||||||||||
| n=3581 | n=3091 | n=490 | n=1941 | n=1640 | n=2539 | n=1042 | ||||||||||||
| N | % | N | % | N | % | P value | N | % | N | % | P value | N | % | N | % | P value | ||
| Age | (Mean, SD) | 76.61 | 13.32 | 77.32 | 13.06 | 72.18 | 14.08 | <0.001 | 77.63 | 12.92 | 75.41 | 13.69 | <0.001 | 77.21 | 13.31 | 75.16 | 13.26 | <0.001 |
| Gender | Female | 1596 | 44.6 | 1394 | 45.1 | 202 | 41.2 | 0.109 | 905 | 46.6 | 691 | 42.1 | 0.007 | 1155 | 45.5 | 441 | 42.3 | 0.083 |
| Male | 1985 | 55.4 | 1697 | 54.9 | 288 | 58.8 | 1036 | 53.4 | 949 | 57.9 | 1384 | 54.5 | 601 | 57.7 | ||||
| Ethnicity | White | 1511 | 42.2 | 1330 | 43.0 | 181 | 36.9 | 0.001 | 866 | 44.6 | 645 | 39.3 | 0.006 | 1114 | 43.9 | 397 | 38.1 | <0.001 |
| Black | 232 | 6.5 | 195 | 6.3 | 37 | 7.6 | 115 | 5.9 | 117 | 7.1 | 147 | 5.8 | 85 | 8.2 | ||||
| Asian | 490 | 13.7 | 396 | 12.8 | 94 | 19.2 | 240 | 12.4 | 250 | 15.2 | 313 | 12.3 | 177 | 17.0 | ||||
| Mixed | 523 | 14.6 | 447 | 14.5 | 76 | 15.5 | 270 | 13.9 | 253 | 15.4 | 380 | 15.0 | 143 | 13.7 | ||||
| Other | 177 | 4.9 | 149 | 4.8 | 28 | 5.7 | 104 | 5.4 | 73 | 4.5 | 127 | 5.0 | 50 | 4.8 | ||||
| Missing | 648 | 18.1 | 574 | 18.6 | 74 | 15.1 | 346 | 17.8 | 302 | 18.4 | 458 | 18.0 | 190 | 18.2 | ||||
| IMD quintile | 1 (most deprived) | 604 | 16.9 | 499 | 16.1 | 105 | 21.4 | 0.047 | 319 | 16.4 | 285 | 17.4 | 0.613 | 414 | 16.3 | 190 | 18.2 | 0.536 |
| 2 | 1135 | 31.7 | 983 | 31.8 | 152 | 31.0 | 612 | 31.5 | 523 | 31.9 | 804 | 31.7 | 331 | 31.8 | ||||
| 3 | 894 | 25.0 | 776 | 25.1 | 118 | 24.1 | 474 | 24.4 | 420 | 25.6 | 642 | 25.3 | 252 | 24.2 | ||||
| 4 | 540 | 15.1 | 467 | 15.1 | 73 | 14.9 | 310 | 16.0 | 230 | 14.0 | 383 | 15.1 | 157 | 15.1 | ||||
| 5 (least deprived) | 299 | 8.3 | 268 | 8.7 | 31 | 6.3 | 167 | 8.6 | 132 | 8.0 | 222 | 8.7 | 77 | 7.4 | ||||
| Missing | 109 | 3.0 | 98 | 3.2 | 11 | 2.2 | 59 | 3.0 | 50 | 3.0 | 74 | 2.9 | 35 | 3.4 | ||||
| Lived in care home | No | 3389 | 94.6 | 2910 | 94.1 | 479 | 97.8 | 0.001 | 1797 | 92.6 | 1592 | 97.1 | <0.001 | 2387 | 94.0 | 1002 | 96.2 | 0.010 |
| Yes | 192 | 5.4 | 181 | 5.9 | 11 | 2.2 | 144 | 7.4 | 48 | 2.9 | 152 | 6.0 | 40 | 3.8 | ||||
| Number QoF comorbidities | 0 | 579 | 16.2 | 489 | 15.8 | 90 | 18.4 | 0.184 | 304 | 15.7 | 275 | 16.8 | 0.041 | 398 | 15.7 | 181 | 17.4 | 0.036 |
| 1 | 856 | 23.9 | 750 | 24.3 | 106 | 21.6 | 495 | 25.5 | 361 | 22.0 | 641 | 25.2 | 215 | 20.6 | ||||
| 2 | 756 | 21.1 | 657 | 21.3 | 99 | 20.2 | 401 | 20.7 | 355 | 21.6 | 534 | 21.0 | 222 | 21.3 | ||||
| 3 | 628 | 17.5 | 529 | 17.1 | 99 | 20.2 | 353 | 18.2 | 275 | 16.8 | 445 | 17.5 | 183 | 17.6 | ||||
| ≥4 | 762 | 21.3 | 666 | 21.5 | 96 | 19.6 | 388 | 20.0 | 374 | 22.8 | 521 | 20.5 | 241 | 23.1 | ||||
| QoF comorbidities | COPD (yes) | 535 | 14.9 | 456 | 14.8 | 79 | 16.1 | 0.429 | 266 | 13.7 | 269 | 16.4 | 0.024 | 371 | 14.6 | 164 | 15.7 | 0.390 |
| Depression (yes) | 625 | 17.5 | 539 | 17.4 | 86 | 17.6 | 0.951 | 330 | 17.0 | 295 | 18.0 | 0.439 | 446 | 17.6 | 179 | 17.2 | 0.781 | |
| Diabetes (yes) | 996 | 27.8 | 855 | 27.7 | 141 | 28.8 | 0.609 | 522 | 26.9 | 474 | 28.9 | 0.181 | 682 | 26.9 | 314 | 30.1 | 0.047 | |
| Hypertension (yes) | 2022 | 56.5 | 1753 | 56.7 | 269 | 54.9 | 0.452 | 1101 | 56.7 | 921 | 56.2 | 0.734 | 1441 | 56.8 | 581 | 55.8 | 0.585 | |
| Dementia (yes) | 328 | 9.2 | 300 | 9.7 | 28 | 5.7 | 0.004 | 202 | 10.4 | 126 | 7.7 | 0.005 | 246 | 9.7 | 82 | 7.9 | 0.086 | |
| CHD (yes) | 689 | 19.2 | 596 | 19.3 | 93 | 19.0 | 0.875 | 354 | 18.2 | 335 | 20.4 | 0.098 | 463 | 18.2 | 226 | 21.7 | 0.017 | |
| Type of cancer | Bowel | 416 | 11.6 | 374 | 12.1 | 42 | 8.6 | 0.075 | 234 | 12.1 | 182 | 11.1 | 0.215 | 288 | 11.3 | 128 | 12.3 | 0.032 |
| Lung | 769 | 21.5 | 646 | 20.9 | 123 | 25.1 | 392 | 20.2 | 377 | 23.0 | 520 | 20.5 | 249 | 23.9 | ||||
| Prostate | 309 | 8.6 | 260 | 8.4 | 49 | 10.0 | 169 | 8.7 | 140 | 8.5 | 223 | 8.8 | 86 | 8.3 | ||||
| Breast | 237 | 6.6 | 205 | 6.6 | 32 | 6.5 | 117 | 6.0 | 120 | 7.3 | 155 | 6.1 | 82 | 7.9 | ||||
| Pancreas | 194 | 5.4 | 167 | 5.4 | 27 | 5.5 | 103 | 5.3 | 91 | 5.5 | 142 | 5.6 | 52 | 5.0 | ||||
| Haematolo | 137 | 3.8 | 114 | 3.7 | 23 | 4.7 | 75 | 3.9 | 62 | 3.8 | 95 | 3.7 | 42 | 4.0 | ||||
| Other | 1519 | 42.4 | 1325 | 42.9 | 194 | 39.6 | 851 | 43.8 | 668 | 40.7 | 1116 | 44.0 | 403 | 38.7 | ||||
CHD, chronic heart disease; COPD, chronic obstructive pulmonary disease; ED, emergency department visits; EHA, emergency hospital admissions; IMD, Index of Multiple Deprivation; QoF, quality of outcomes framework.
Healthcare services utilisation in the last 3 months of life by outcome measure
| 3 or more EHA in the last 3 months | 1 or more EHA in the last month | 1 or more ED visits in the last 2 weeks | |||||||||||||
| No | Yes | No | Yes | No | Yes | ||||||||||
| N | % | N | % | P value* | N | % | N | % | P value* | N | % | N | % | P value* | |
|
| |||||||||||||||
| 1812 | 58.6 | 243 | 49.6 | 1144 | 58.9 | 911 | 55.5 | 1499 | 59.0 | 556 | 53.4 | ||||
| 873 | 28.2 | 149 | 30.4 | 539 | 27.8 | 483 | 29.5 | 705 | 27.8 | 317 | 30.4 | ||||
| 406 | 13.1 | 98 | 20.0 | <0.001 | 258 | 13.3 | 246 | 15.0 | 0.105 | 355 | 14.0 | 169 | 16.2 | 0.014 | |
|
| |||||||||||||||
| 1629 | 52.7 | 244 | 49.8 | 995 | 51.3 | 878 | 53.5 | 1300 | 51.2 | 573 | 55.0 | ||||
| 712 | 23.0 | 123 | 25.1 | 420 | 21.6 | 415 | 25.3 | 582 | 22.9 | 253 | 24.3 | ||||
| 725 | 23.5 | 117 | 23.9 | 0.475 | 504 | 26.0 | 338 | 20.6 | <0.001 | 632 | 24.9 | 210 | 20.2 | 0.008 | |
|
| |||||||||||||||
| 2652 | 85.8 | 432 | 88.2 | 1644 | 84.7 | 1440 | 87.8 | 2170 | 85.5 | 914 | 87.7 | ||||
| 313 | 10.1 | 40 | 8.2 | 206 | 10.6 | 147 | 9.0 | 254 | 10.0 | 99 | 9.5 | ||||
| 126 | 4.1 | 18 | 3.7 | 0.350 | 91 | 4.7 | 53 | 3.2 | 0.017 | 115 | 4.5 | 29 | 2.8 | 0.044 | |
|
| |||||||||||||||
| 2830 | 91.6 | 450 | 91.8 | 1760 | 90.7 | 1520 | 92.7 | 2321 | 91.4 | 959 | 92.0 | ||||
| 186 | 6.0 | 29 | 5.9 | 127 | 6.5 | 88 | 5.4 | 153 | 6.0 | 62 | 6.0 | ||||
| 75 | 2.4 | 11 | 2.2 | 0.966 | 54 | 2.8 | 32 | 2.0 | 0.082 | 65 | 2.6 | 21 | 2.0 | 0.622 | |
|
|
| ||||||||||||||
| 11.85 | (14.15) | 24.98 | (13.32) | 10.21 | (14.9) | 17.71 | (13.48) | 13.1 | (15.21) | 14.98 | (13.46) | ||||
| 7 | (0.0–19.0) | 23 | (15.0–32.0) | <0.001 | 2 | (0.0–16.0) | 15 | (8.0–25.0) | <0.001 | 8 | (0.0–20.0) | 11 | (5.0–21.0) | <0.001 | |
*χ2 for trend p value.
†Wilcoxon rank-sum test p value.
ED, emergency department visits; EHA, emergency hospital admissions; GP, general practitioner.
Association between sociodemographic, illness-related and service-related factors with three outcome measures for acute end-of-life care in the last 3 months of life
| 3 or more EHA last 3 months | 1 or more EHA last month | 1 or more ED last 2 weeks | ||||||||||
| n=3472 | n=3441 | n=3441 | ||||||||||
| Univariate | Multivariate | Univariate | Multivariate | Univariate | Multivariate | |||||||
| RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | |
| Age | 0.98 | (0.97 to 0.99) | 0.98 | (0.97 to 0.99) | 0.99 | (0.99 to 0.10) | 0.99 | (0.99 to 1.00) | 0.99 | (0.99 to 1.00) | 0.99 | (0.99 to 1.00) |
| Gender (ref. female) | ||||||||||||
| Male | 1.15 | (0.97 to 1.36) | 1.10 | (0.92 to 1.31) | 1.10 | (1.02 to 1.20) | 1.11 | (1.02 to 1.20) | 1.09 | (0.98 to 1.21) | 1.10 | (0.98 to 1.23) |
| IMD quintile (ref. 1, most deprived) | ||||||||||||
| 2 | 0.79 | (0.63 to 0.99) | 0.82 | (0.65 to 1.03) | 1.00 | (0.90 to 1.12) | 1.01 | (0.91 to 1.12) | 0.97 | (0.84 to 1.11) | 1.01 | (0.89 to 1.15) |
| 3 | 0.80 | (0.62 to 1.02) | 0.88 | (0.70 to 1.12) | 1.01 | (0.90 to 1.13) | 1.03 | (0.92 to 1.15) | 0.90 | (0.77 to 1.06) | 0.93 | (0.80 to 1.15) |
| 4 | 0.82 | (0.62 to 1.08) | 0.96 | (0.75 to 1.24) | 0.92 | (0.81 to 1.05) | 0.96 | (0.85 to 1.09) | 0.95 | (0.80 to 1.13) | 1.00 | (0.84 to 1.18) |
| 5 | 0.68 | (0.49 to 0.93) | 0.95 | (0.68 to 1.31) | 0.97 | (0.81 to 1.16) | 1.06 | (0.90 to 1.25) | 0.88 | (0.71 to 1.10) | 0.98 | (0.79 to 1.22) |
| Lived in care home (ref. no) | 0.43 | (0.24 to 0.78) | 0.53 | (0.28 to 0.98) | 0.54 | (0.41 to 0.72) | 0.54 | (0.41 to 0.72) | 0.71 | (0.51 to 0.99) | 0.70 | (0.49 to 0.99) |
| Type of cancer (ref. bowel) | ||||||||||||
| Lung | 1.53 | (1.13 to 2.06) | 1.60 | (1.16 to 2.20) | 1.11 | (0.98 to 1.25) | 1.08 | (0.96 to 2.23) | 1.04 | (0.88 to 1.22) | 1.01 | (0.85 to 1.19) |
| Prostate | 1.57 | (1.09 to 2.28) | 1.57 | (1.07 to 2.30) | 1.03 | (0.89 to 1.21) | 0.98 | (0.84 to 2.15) | 0.91 | (0.74 to 1.11) | 0.89 | (0.72 to 1.10) |
| Breast | 1.32 | (0.88 to 1.97) | 1.24 | (0.82 to 1.87) | 1.15 | (0.98 to 1.34) | 1.19 | (1.02 to 1.39) | 1.11 | (0.93 to 1.34) | 1.16 | (0.94 to 1.42) |
| Pancreas | 1.34 | (0.88 to 2.04) | 1.23 | (0.93 to 2.08) | 1.05 | (0.89 to 1.25) | 1.02 | (0.87 to 2.20) | 0.85 | (0.67 to 1.09) | 0.82 | (0.63 to 1.06) |
| Haematological | 1.63 | (1.01 to 2.61) | 1.23 | (0.73 to 2.07) | 1.03 | (0.83 to 1.29) | 0.91 | (0.72 to 2.15) | 0.98 | (0.74 to 1.31) | 0.93 | (0.68 to 1.26) |
| Other | 1.24 | (0.91 to 1.69) | 1.15 | (0.83 to 1.58) | 1.00 | (0.88 to 1.12) | 0.96 | (0.86 to 1.08) | 0.85 | (0.73 to 0.99) | 0.82 | (0.70 to 0.96) |
| Number QoF comorbidities (ref. 0) | ||||||||||||
| 1 | 0.81 | (0.64 to 1.03) | 0.88 | (0.69 to 1.11) | 0.90 | (0.81 to 1.00) | 0.92 | (0.83 to 1.02) | 0.82 | (0.70 to 0.96) | 0.88 | (0.75 to 1.04) |
| 2 | 0.83 | (0.65 to 1.07) | 0.99 | (0.76 to 1.30) | 0.99 | (0.89 to 1.10) | 1.06 | (0.95 to 1.18) | 0.95 | (0.81 to 1.11) | 1.05 | (0.89 to 1.25) |
| 3 | 1.01 | (0.79 to 1.29) | 1.23 | (0.94 to 1.62) | 0.92 | (0.82 to 1.04) | 0.99 | (0.87 to 1.12) | 0.93 | (0.79 to 1.10) | 1.01 | (0.84 to 1.21) |
| ≥4 | 0.80 | (0.62 to 1.04) | 0.98 | (0.74 to 1.30) | 1.04 | (0.92 to 1.17) | 1.11 | (0.97 to 1.27) | 1.01 | (0.86 to 1.18) | 1.09 | (0.89 to 1.32) |
| QoF comorbidities (ref. no) | ||||||||||||
| COPD | 1.09 | (0.88 to 1.34) | * | * | 1.11 | (1.01 to 1.23) | 1.07 | (0.97 to 1.19) | 1.05 | (0.91 to 1.21) | * | * |
| Depression | 1.01 | (0.84 to 1.22) | * | * | 1.04 | (0.94 to 1.14) | * | * | 0.98 | (0.86 to 1.11) | * | * |
| Diabetes | 1.02 | (0.86 to 1.22) | * | * | 1.04 | (0.97 to 1.12) | * | * | 1.09 | (0.97 to 1.22) | * | * |
| Hypertension | 0.92 | (0.79 to 1.07) | * | * | 0.98 | (0.92 to 1.05) | * | * | 0.96 | (0.87 to 1.07) | * | * |
| Dementia | 0.62 | (0.44 to 0.88) | 0.78 | (0.54 to 1.14) | 0.84 | (0.73 to 0.97) | 0.94 | (0.82 to 1.07) | 0.86 | (0.70 to 1.06) | * | * |
| CHD | 0.99 | (0.82 to 1.20) | * | * | 1.08 | (0.99 to 1.18) | * | * | 1.16 | (1.03 to 1.30) | 1.14 | (0.99 to 1.31) |
| Contacts with GP practice (ref. 0–3) | ||||||||||||
| 4–10 | 1.21 | (1.01 to 1.46) | 1.18 | (0.98 to 1.41) | 1.05 | (0.97 to 1.13) | * | * | 1.12 | (1.00 to 1.24) | 1.10 | (0.98 to 1.22) |
| ≥11 | 1.59 | (1.29 to 1.95) | 1.63 | (1.33 to 1.99) | 1.08 | (0.98 to 1.19) | * | * | 1.19 | (1.03 to 1.38) | 1.27 | (1.10 to 1.47) |
| Contacts with community nurses (ref. 0–3) | ||||||||||||
| 4–12 | 1.08 | (0.90 to 1.29) | * | * | 1.04 | (0.96 to 1.13) | 1.06 | (0.98 to 1.15) | 0.97 | (0.86 to 1.10) | 0.96 | (0.85 to 1.08) |
| ≥13 | 1.01 | (0.83 to 1.24) | * | * | 0.84 | (0.76 to 0.93) | 0.88 | (0.90 to 0.98) | 0.80 | (0.69 to 0.93) | 0.79 | (0.68 to 0.92) |
| Contacts with community palliative care teams (ref. 0–3) | ||||||||||||
| 4–8 | 0.88 | (0.68 to 1.15) | * | * | 0.91 | (0.80 to 1.04) | 0.95 | (0.82 to 1.08) | 0.97 | (0.82 to 1.14) | 1.01 | (0.85 to 1.21) |
| ≥9 | 0.93 | (0.62 to 1.37) | * | * | 0.78 | (0.63 to 0.96) | 0.85 | (0.69 to 1.04) | 0.70 | (0.50 to 0.97) | 0.78 | (0.56 to 1.08) |
| Contacts with rehabilitation teams (ref. 0) | ||||||||||||
| 1–3 | 1.01 | (0.73 to 1.38) | * | * | 0.89 | (0.76 to 1.05) | * | * | 1.01 | (0.82 to 1.25) | * | * |
| ≥4 | 0.93 | (0.55 to 1.58) | * | * | 0.80 | (0.61 to 1.04) | * | * | 0.81 | (0.57 to 1.15) | * | * |
| Days in hospital | 0.94 | (0.94 to 0.95) | 1.04 | (1.03 to 1.04) | 1.02 | (1.01 to 1.02) | 1.02 | (1.01 to 1.02) | 1.00 | (0.99 to 1.00) | 1.00 | (1.00 to 1.01) |
*Variable not included in the model.
CHD, chronic heart disease; COPD, chronic obstructive pulmonary disease; ED, emergency department visit; EHA, emergency hospital admissions; IMD, Index of Multiple Deprivation; QoF, quality of outcomes framework; RR, risk ratio.